NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
Clinical Trials
3 trialsNCT03253250 2017-09-08
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection
Huashan Hospital
Phase 4 Unknown
NCT00834860 2010-02-15
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase 4 Unknown